临床内科杂志
臨床內科雜誌
림상내과잡지
JOURNAL OF CLINICAL INTERNAL MEDICINE
2009年
5期
337-339
,共3页
血管内皮生长因子%细胞角蛋白19片段%胸腔积液%肺结核%肺癌
血管內皮生長因子%細胞角蛋白19片段%胸腔積液%肺結覈%肺癌
혈관내피생장인자%세포각단백19편단%흉강적액%폐결핵%폐암
VEGF%CYFRA21-1%Pleural effusion%Pulmonary tuberculosis%Pulmonary carcinoma
目的 探讨联合检测血清和胸腔积液中血管内皮生长因子、细胞角蛋白19片段对鉴别结核性与肺癌性胸腔积液的临床价值.方法 分别采用双抗体夹心酶联免疫吸附和电化学发光免疫法检测肺癌性和结核性胸腔积液患者血清和胸腔积液中血管内皮生长因子及细胞角蛋白19片段的表达水平.结果 肺癌性胸腔积液患者血清和胸腔积液中血管内皮生长因子及细胞角蛋白19片段的表达水平比较有统计学意义(P<0.01),联合检测可使敏感性提高至92.00%,特异性提高至 86.84%.结论 联合检测胸腔积液和血清中血管内皮生长因子、细胞角蛋白19片段,对鉴别肺癌性与结核性胸腔积液具有重要的临床价值.
目的 探討聯閤檢測血清和胸腔積液中血管內皮生長因子、細胞角蛋白19片段對鑒彆結覈性與肺癌性胸腔積液的臨床價值.方法 分彆採用雙抗體夾心酶聯免疫吸附和電化學髮光免疫法檢測肺癌性和結覈性胸腔積液患者血清和胸腔積液中血管內皮生長因子及細胞角蛋白19片段的錶達水平.結果 肺癌性胸腔積液患者血清和胸腔積液中血管內皮生長因子及細胞角蛋白19片段的錶達水平比較有統計學意義(P<0.01),聯閤檢測可使敏感性提高至92.00%,特異性提高至 86.84%.結論 聯閤檢測胸腔積液和血清中血管內皮生長因子、細胞角蛋白19片段,對鑒彆肺癌性與結覈性胸腔積液具有重要的臨床價值.
목적 탐토연합검측혈청화흉강적액중혈관내피생장인자、세포각단백19편단대감별결핵성여폐암성흉강적액적림상개치.방법 분별채용쌍항체협심매련면역흡부화전화학발광면역법검측폐암성화결핵성흉강적액환자혈청화흉강적액중혈관내피생장인자급세포각단백19편단적표체수평.결과 폐암성흉강적액환자혈청화흉강적액중혈관내피생장인자급세포각단백19편단적표체수평비교유통계학의의(P<0.01),연합검측가사민감성제고지92.00%,특이성제고지 86.84%.결론 연합검측흉강적액화혈청중혈관내피생장인자、세포각단백19편단,대감별폐암성여결핵성흉강적액구유중요적림상개치.
Objective To evaluate the significance of combined detection of vascular endothelial growth factors (VEGF) and cytokeratin 19 fragment (CYFRA21-1) in serum and pleural effusion in differentiating tuberculous pleural effusion from pulmonary carcinoma caused by lung cancer.Methods Levels of VEGF and CYFRA21-1 in serum and pleural effusion in patients with pulmonary carcinoma and tuberculosis were detected.Sensitivity ratios of VEGF,CYFRA21-1 and combined detection were obtained.Results Levels and positive rate of VEGF and CYFRA21-1 in serum and pleural effusion in patients with pulmonary carcinoma were significantly higher than that in patients with tuberculosis (P<0.01).The sensitivity and specificity of the combined detection of VEGF and CYFRA21-1 in serum and pleural effusion were high compared with those of single index.Conclusion Combined detection of VEGF and CYFRA21-1 in serum and pleural effusion was of great clinical value in differentiating tuberculous pleural effusion from pulmonary carcinoma caused by lung cancer.